CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
BRIDGING-RD focuses on enhancing research capabilities for rare genetic diseases by improving data interoperability, bioinformatics, and drug testing. It aims to foster collaboration between Serbian and European institutions to accelerate diagnosis and treatment development for affected individuals.
There are over 330 million people living on the planet affected by one of over 6,000 identified genetic rare diseases (RD).
They urgently need timely diagnosis and development of specific treatments.
Although Europe leads the way in RD research, there is a clear gap in research and innovation (R&I) between countries.
To bridge this gap, networking and knowledge sharing between IMGGE (Institute of Molecular Genetics and Genetic Engineering, Serbia) and 3 world-class counterparts at EU level - KI…
INSTITUT ZA MOLEKULARNU GENETIKU I GENETICKO INZENJERSTVO
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Sweden, Stockholm
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
CONSORCIO PARA LA EXPLOTACION DEL CENTRO NACIONAL DE ANALISIS GENOMICO
Spain, Barcelona
Type: Research institute
Activity type: Research Organisations
SME: No
Spain, Madrid
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 topics.
Guests see up to 5 keywords.
